PRTODAY / NewswireToday Free press release distribution service network

More news: Health/Surgery
Written by / Agency / Source: Image Skin Institute

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Valley Dermatologist to Conduct Juvéderm™ Clinical Trials - Dr. Stephen E. Kessler, a Mesa dermatologic surgeon, announced that he has been approached by the makers of Botox® Cosmetic to perform clinical trials of their new anti-wrinkle drug Juvéderm™, a possible competitor to the popular Restylane® treatment
Valley Dermatologist to Conduct Juvéderm™ Clinical Trials

 

NewswireToday - /newswire/ - Mesa, AZ, United States, 2006/10/25 - Dr. Stephen E. Kessler, a Mesa dermatologic surgeon, announced that he has been approached by the makers of Botox® Cosmetic to perform clinical trials of their new anti-wrinkle drug Juvéderm™, a possible competitor to the popular Restylane® treatment.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Dr. Stephen E. Kessler, D.O., a Mesa dermatologic surgeon, has been approached by Allergan Inc., makers of the popular anti-wrinkle treatment Botox® Cosmetic, to perform clinical trials of their new anti-wrinkle drug Juvéderm™ in advance of its national release in January 2007.

Juvéderm™ is a dermal filler that is especially effective at restoring volume and smoothness to the lips and the folds around the nose and mouth. Already approved by the FDA, Juvéderm™ will begin patient trials on November 1st at select clinical sites throughout the United States. Dr. Kessler was chosen by Allergan to participate in the clinical trials because of his demonstrated excellence in the administration of Botox® Cosmetic. He was among the first dermatologists in Arizona to use Botox® cosmetically, and has been awarded Platinum status by Allergan, having treated over 2,000 patients with Botox® Cosmetic since early 2000.

Juvéderm™ is being touted as a “next generation” dermal filler because of its smooth formulation and long-lasting effects. Unlike other current dermal fillers that use hyaluronic acid, such as Restylane® (1), Juvéderm™ has no visible gel particles in its formulation. Early patient trials have indicated that this may offer smoother skin and more natural looking results. In addition, Juvéderm™ offers the highest concentration of hyaluronic acid available in a dermal filler, which may allow for longer-lasting results.

Dr. Kessler, who has treated over 250 patients with Restylane®, says, “All indications are that Juvéderm™ may solve many of the issues that patients currently have with dermal fillers. Namely, the problems of an uneven feel to the skin, and the lack of a good long term solution.”

Juvéderm™ could spell trouble for the current leader in the dermal filler field, Restylane®, which is a product of Scottsdale-based Medicis Pharmaceutical Corp. Restylane® currently dominates the $200 million to $300 million industry, but many analysts predict Juvéderm™ could affect its sales drastically.

"I expect most of the growth over the next few years to come from Juvéderm™, primarily because Allergan will be able to leverage the Botox®-Juvéderm™ combination," said Jose Haresco, analyst for Merriman, Curhan, Ford & Co. "It's the one-stop shopping experience.” (2)

Says Bank of America analyst David Maris, "Based on our discussions with leading cosmetic surgeons/dermatologists, we believe that because of its longer duration, Juvéderm™ is likely to be a better product versus Medicis' Restylane®.” (3)

(1) Source: juvedermcomingsoon.com
(2) Source: money.cnn.com
(3) Source: msnbc.com

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Image Skin Institute

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Valley Dermatologist to Conduct Juvéderm™ Clinical Trials

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Steven Canavan - ImageSkinInstitute.com 
650-346-3164 steven.canavan[.]gmail.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Image Skin Institute securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Image Skin Institute / Company Profile


Read Health/Surgery Most Recent Related Newswires:

Sustainable Alternatives to Polyvinylidene Chloride-coated Films Create Growth Opportunities & Transform the Food Packaging Markets in Western Europe
RIKEN Biofunctional Synthetic Chemistry Laboratory in Japan Has Developed A Way to Engineer Glycan Complexes Clusters of Sugar Chains
The Clinicians of Longs Peak Emergency Physicians Join US Acute Care Solutions
Frost & Sullivan Recognizes BroadReach for Improving the Health and Wellbeing of Underserved Populations
Silver Spring Emergency Physicians Join US Acute Care Solutions
Stress Light Therapy Launches Crowd-Funded Campaign on Indiegogo.com
The Float Space - Brisbane's First Float and Cryo Therapy Centre to Open This November
Thought Leaders Across the Healthcare Spectrum to Participate in Industry-Wide Survey
Frost & Sullivan Names Optum 2016 North America Company of the Year for Population Health Management
R-Pharm Produces Biological Drugs in Yaroslavl with GE Healthcare's FlexFactory™ Manufacturing Platform
GE to Invest €150 Million in Biopharmaceutical Manufacturing Campus in Cork, Ireland, and Establish Advanced Manufacturing Training Centre At NIBRT
Moriarty Physical Therapy of the Hudson Valley Expands with New Office in Lagrange, NY
Ultimate Medical Group Announces A New Regenerative Medicine Division
Dr. Amir Hanna Introduces New Medical Innovation Taking the Pain Out of Physical Therapy
Samitivej Children’s Hospital Transforms its Sukhumvit Campus

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  JobsWare.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)